Page last updated: 2024-12-08
3-mercaptohexyl acetate
Description
3-mercaptohexyl acetate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-mercaptohexyl acetate : An acetate ester obtained by formal O-acetylation of 3-mercaptohexanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 518810 |
CHEBI ID | 77818 |
SCHEMBL ID | 112254 |
MeSH ID | M0501939 |
Synonyms (33)
Synonym |
3-sulfanylhexyl acetate |
3-mercaptohexyl acetate |
AKOS006345214 |
136954-20-6 |
unii-2n346iqc0m |
2n346iqc0m , |
1-hexanol, 3-mercapto-, 1-acetate |
LMFA05000540 |
3-thiohexyl acetate |
FT-0643262 |
SCHEMBL112254 |
(+/-)-3-sulfanylhexyl acetate |
3-sulfanylhexyl acetate, (+/-)- |
fema no. 3851, pure- |
CHEBI:77818 |
mfcd00792516 |
hexane-3-thiol acetate |
3-sulfanylhexyl acetate # |
JUCARGIKESIVLB-UHFFFAOYSA-N |
M2497 |
acetic acid 3-mercaptohexyl ester |
J-800447 |
J-640414 |
AS-61325 |
3-mercaptohexyl acetate, >=98%, fg |
(s)-3-mercaptohexyl acetate |
3-mercaptohexylacetate |
J-006942 |
DTXSID50869866 |
Q27147423 |
AMY24734 |
D91605 |
biotin-nhs?(+)-biotin n-hydroxysuccinimide ester |
Roles (1)
Role | Description |
Saccharomyces cerevisiae metabolite | Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae). |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
acetate ester | Any carboxylic ester where the carboxylic acid component is acetic acid. |
alkanethiol | An alkanethiol is a compound in which a sulfanyl group, -SH, is attached to an alkyl group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 25.77
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 25.77 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.73 (4.65) | Search Engine Demand Index | 26.67 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |